Shanghai - Delayed Quote CNY
Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)
47.40
+3.80
+(8.72%)
At close: 3:00:04 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,155,027.95
2,969,770.57
2,225,594.09
1,731,716.46
1,787,028.56
Cost of Revenue
815,819.68
781,028.91
652,221.96
547,288.93
643,036.82
Gross Profit
2,339,208.27
2,188,741.66
1,573,372.13
1,184,427.53
1,143,991.75
Operating Expense
1,947,046.85
1,828,856.14
1,372,936.91
1,010,979.73
893,731.72
Operating Income
392,161.43
359,885.52
200,435.22
173,447.80
250,260.03
Net Non Operating Interest Income Expense
17,817.58
14,283.03
15,071.08
13,966.51
34,465.68
Pretax Income
417,117.94
380,656.51
317,086.27
206,581.47
309,625.39
Tax Provision
50,180.65
38,292.62
39,496.57
39,150.31
68,433.21
Net Income Common Stockholders
366,045.02
341,628.71
259,417.88
174,183.37
247,921.31
Basic EPS
0.91
0.85
0.65
0.43
0.62
Diluted EPS
0.91
0.85
0.65
0.43
0.62
Basic Average Shares
402,438.29
401,916.13
399,104.42
405,077.61
399,873.09
Diluted Average Shares
402,438.29
401,916.13
399,104.42
405,077.61
399,873.09
Total Operating Income as Reported
417,243.90
380,936.81
319,336.60
207,336.72
298,991.36
Total Expenses
2,762,866.53
2,609,885.05
2,025,158.87
1,558,268.66
1,536,768.53
Net Income from Continuing & Discontinued Operation
366,045.02
341,628.71
259,417.88
174,183.37
247,921.31
Normalized Income
372,721.76
353,345.87
206,130.63
179,276.94
257,078.70
Interest Income
27,041.44
24,411.97
21,412.34
16,111.01
35,473.17
Interest Expense
8,983.54
9,637.66
5,926.32
1,861.11
640.03
Net Interest Income
17,817.58
14,283.03
15,071.08
13,966.51
34,465.68
EBIT
426,101.48
390,294.17
323,012.59
208,442.58
310,265.42
EBITDA
426,101.48
418,602.86
347,570.08
234,973.05
330,347.19
Reconciled Cost of Revenue
815,819.68
781,028.91
652,221.96
547,288.93
643,036.82
Reconciled Depreciation
--
28,308.69
24,557.49
26,530.47
20,081.77
Net Income from Continuing Operation Net Minority Interest
366,045.02
341,628.71
259,417.88
174,183.37
247,921.31
Total Unusual Items Excluding Goodwill
-7,589.82
-13,027.70
60,869.17
-6,284.59
-11,755.60
Total Unusual Items
-7,589.82
-13,027.70
60,869.17
-6,284.59
-11,755.60
Normalized EBITDA
433,691.30
431,630.55
286,700.92
241,257.64
342,102.79
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-913.08
-1,310.54
7,581.92
-1,191.02
-2,598.22
12/31/2021 - 7/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade